Breakout 4.2 Optimise not maximise for better value COPD and asthma care - Noel Baxter
-
Upload
nhs-improvement -
Category
Health & Medicine
-
view
581 -
download
3
description
Transcript of Breakout 4.2 Optimise not maximise for better value COPD and asthma care - Noel Baxter
1
Noel Baxter GP
Co-lead NHS London Respiratory Team
Optimise not maximise for
better value COPD & asthma
care
The VALUE equation
Health
Outcomes Patient defined
bundle of care
Cost Value =
Health Outcomes
Cost of delivering
Outcomes
Porter ME; Lee TH NEJM 2010;363:2477-2481; 2481-2483
2
We know what interventions are good value –
when they are done in the right way
Triple Therapy
£35,000-£187,000/QALY
LABA
£8,000/QALY
Tiotropium
£7,000/QALY
Pulmonary Rehabilitation
£2,000-8,000/QALY
Stop Smoking Support with pharmacotherapy £2,000/QALY
Flu vaccination £1,000/QALY in “at risk” population
1 year abstinence
%
QALY
£
Usual care 1.4
Minimal counselling 2.6 14,735
Intensive counselling 6 7,149
Intensive counselling +
pharmacotherapy
12.3 2,092
Systematic Review of 9 studies Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Mo¨lken MPMH. Thorax 2010: 65:711-718
A cost effective intervention in COPD - Stopping Smoking
What works long term and is cost effective?
3
The low value pyramid
We know how to allocate resource at
population level http://www.impressresp.com/index.php?option=com_content&view=article&id=167:impressions-28-relative-value-of-copd-interventions&catid=11:impressions&Itemid=3
4
COPD in London: What do we know?
Londoners dying from smoking
‘1 in 5 deaths due to
smoking’
5
Stop smoking support: Step 1 treatment for
people with asthma who smoke and for
households of children with asthma that
smoke
“ 32.5% of patients admitted to hospital were current smokers …a further 18.8% were ex‐smokers …a significantly greater number of asthmatics reported themselves to be smokers over the general population … … smoking causes steroid resistance in asthma and is associated with other ‘risk’ behaviours, which may make this group more likely to be admitted to hospital
Optimal healthcare for up to 1:4 people with a
long term condition is stop smoking support as
treatment
6
Admissions ( asthma and COPD) : What factors
can we influence as health professionals ?
• Bed capacity
• Distance to hospital
• Deprivation of population
• Socioeconomic status
• Prevalence of COPD
• Prevalence of smoking in our practices
Where can we make an impact for people
with COPD and asthma ?
• For every 1% increase in prevalence of
smoking in your COPD population there is a
1% increase in COPD admission rates.
• For every 1% increase in prevalence of
smoking in your asthma population there is a
1% increase in asthma admission rates.
7
8
PCT monthly COPD dashboard 2013
Prevalence of current
smoking where status
recorded in last 15 months
1550/3335 = 46.5%
COPD smokers in last year receiving evidence based stop smoking
support – 17.5%
Quit smoking as treatment Sharing Whittington learning
Health professionals esp doctors need to believe quit smoking
interventions are part of their role & responsibility
Behaviour change: importance, confidence
Make it easy to do
clinical leadership, systems & incentives
• Brief interventions
• Behaviour change skills
• Knowledge of quit smoking services & referral
• Prescribing knowledge & medications available
• Measure outcomes and provide feedback
• Acute Trust and Mental Health Trust CQINs
9
10
Are your hospital staff able, & confident
to, prescribe Quit Smoking medication?
Does your hospital provide nicotine
replacement therapy routinely on
admission for smokers?
How do we make this happen?
11
What did we do?
More about LRT and Right Care @ www.londonrespiratoryteamconference.com
12